BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24441388)

  • 21. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.
    Nakayama A; Matsuo H; Nakaoka H; Nakamura T; Nakashima H; Takada Y; Oikawa Y; Takada T; Sakiyama M; Shimizu S; Kawamura Y; Chiba T; Abe J; Wakai K; Kawai S; Okada R; Tamura T; Shichijo Y; Akashi A; Suzuki H; Hosoya T; Sakurai Y; Ichida K; Shinomiya N
    Sci Rep; 2014 Jun; 4():5227. PubMed ID: 24909660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
    Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
    Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
    Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
    Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.
    Matsuo H; Tsunoda T; Ooyama K; Sakiyama M; Sogo T; Takada T; Nakashima A; Nakayama A; Kawaguchi M; Higashino T; Wakai K; Ooyama H; Hokari R; Suzuki H; Ichida K; Inui A; Fujimori S; Shinomiya N
    Sci Rep; 2016 Aug; 6():31003. PubMed ID: 27571712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.
    Matsuo H; Yamamoto K; Nakaoka H; Nakayama A; Sakiyama M; Chiba T; Takahashi A; Nakamura T; Nakashima H; Takada Y; Danjoh I; Shimizu S; Abe J; Kawamura Y; Terashige S; Ogata H; Tatsukawa S; Yin G; Okada R; Morita E; Naito M; Tokumasu A; Onoue H; Iwaya K; Ito T; Takada T; Inoue K; Kato Y; Nakamura Y; Sakurai Y; Suzuki H; Kanai Y; Hosoya T; Hamajima N; Inoue I; Kubo M; Ichida K; Ooyama H; Shimizu T; Shinomiya N
    Ann Rheum Dis; 2016 Apr; 75(4):652-9. PubMed ID: 25646370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study.
    Natsuko PD; Laura SC; Denise CC; Lucio VR; Carlos AS; Fausto SM; Ambar LM
    Eur J Med Res; 2022 May; 27(1):62. PubMed ID: 35505381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
    Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
    Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
    Sugimoto R; Watanabe H; Ikegami K; Enoki Y; Imafuku T; Sakaguchi Y; Murata M; Nishida K; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    Kidney Int; 2017 Mar; 91(3):658-670. PubMed ID: 27988213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
    Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
    Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCG2: the molecular mechanisms of urate secretion and gout.
    Woodward OM
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F485-8. PubMed ID: 26136557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
    Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility.
    Nakayama A; Matsuo H; Shimizu T; Ogata H; Takada Y; Nakashima H; Nakamura T; Shimizu S; Chiba T; Sakiyama M; Ushiyama C; Takada T; Inoue K; Kawai S; Hishida A; Wakai K; Hamajima N; Ichida K; Sakurai Y; Kato Y; Shimizu T; Shinomiya N
    Hum Cell; 2013 Dec; 26(4):133-6. PubMed ID: 23990105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
    Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
    Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1β functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-ĸB activation.
    Lu X; Chen M; Shen J; Xu Y; Wu H
    Cell Biol Int; 2019 Mar; 43(3):279-289. PubMed ID: 30632646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetics of hyperuricaemia and gout.
    Reginato AM; Mount DB; Yang I; Choi HK
    Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate.
    Kannangara DR; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR
    Ann Rheum Dis; 2016 Jul; 75(7):1363-6. PubMed ID: 26835700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
    Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
    Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic basis of hyperuricaemia and gout.
    Merriman TR; Dalbeth N
    Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.